Zakrzewski Joseph S's Form 4 filing
AN2 Therapeutics, Inc. (ANTX) · filed Nov 20, 2024
- Accession no.
- 0000950170-24-129248
- Filed
- Nov 20, 2024
- Trade date
- Nov 18-19, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $25.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zakrzewski Joseph SCIK 0001331852 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Common Stock | PPurchaseAcquired | +20,000 | $1.00 | +$20,000 | 118,199 | Direct | |
| Nov 19, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $1.01 | +$5,050 | 123,199 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.